# Ipsen BioPharm Ltd - Inspection Records

Source: https://www.keypedia.com/companies/ipsen-biopharm-ltd/282b5a9a-91d6-43f7-b345-aa6fede30025

> Inspection records and compliance data for Ipsen BioPharm Ltd in Wrexham, None. Access full analysis and detailed observations.

---

## Details

- Name: Ipsen BioPharm Ltd
- FEI Number: 1000346340
- City: Wrexham
- State: None
- Country Name: United Kingdom
- Address Line 1: Unit 9, Ash Road North
- Zip Code: None

## Related Documents

- [FDA Inspection 1283174 - Ipsen BioPharm Ltd - 2025-05-22](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/6d909980-a72d-40f9-b745-01581d7ad841) — source: FDA, date: May 22, 2025
- [FDA Inspection 1283174 - Ipsen BioPharm Ltd - 2025-05-22](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/896e1ea1-ceca-49a8-b29d-2432591f8ae9) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 22, 2025
- [FDA Inspection 1117834 - Ipsen BioPharm Ltd - 2019-04-26](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/030c0ad9-b971-4f31-8860-f378e3208168) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 26, 2019
- [FDA Inspection 1059005 - Ipsen BioPharm Ltd - 2018-07-06](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/69366ac8-adf9-4c93-9106-0b8e9dab48c7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 6, 2018
- [FDA Inspection 1026364 - Ipsen BioPharm Ltd - 2017-09-12](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/997abaeb-150c-4efd-9606-322cf0210140) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 12, 2017
- [FDA Inspection 965116 - Ipsen BioPharm Ltd - 2016-01-20](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/63f54633-9023-48a5-ad65-e3a25f7720f2) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 20, 2016
- [FDA Inspection 892573 - Ipsen BioPharm Ltd - 2014-07-08](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/375c7919-25f7-4eb3-ac17-4dc023972e9e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 8, 2014
- [FDA Inspection 801044 - Ipsen BioPharm Ltd - 2012-09-18](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/bf779b90-e989-423e-9c56-b16855042f23) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 18, 2012
- [FDA Inspection 675223 - Ipsen BioPharm Ltd - 2010-07-12](https://www.keypedia.com/records/fda_inspections/ipsen-biopharm-ltd/73491e39-67f1-4d7f-843e-833034bc7b83) — classification: No Action Indicated (NAI), source: FDA, date: July 12, 2010

## Related Companies

- [GE Healthcare Inc.](https://www.keypedia.com/companies/ge-healthcare-inc/b959f09c-3de8-449e-bed3-d919c59edf59)
- [TriRx Speke Limited](https://www.keypedia.com/companies/trirx-speke-limited/51c2b1a3-44be-420c-83eb-3eb1dee37cea)
- [Elanco Clinton Laboratories](https://www.keypedia.com/companies/elanco-clinton-laboratories/89925321-ecbd-43b1-b3a1-472fd17439a0)
- [Excella GmbH & Co. KG](https://www.keypedia.com/companies/excella-gmbh-co-kg/82bb94ef-8b2e-4e51-8c40-b71a184257f1)
- [GE Healthcare AS](https://www.keypedia.com/companies/ge-healthcare-as/1b18a0cb-bd39-4d75-b4c3-3540b36621e0)
- [The Procter & Gamble Manufacturing Company](https://www.keypedia.com/companies/the-procter-gamble-manufacturing-company/c23efaf8-7ca9-487e-8673-c7ba4ae59e53)
- [Reliance Life Sciences Private Limited](https://www.keypedia.com/companies/reliance-life-sciences-private-limited/14b16d70-e482-4647-a231-4eb4a1aab98f)
- [Particle Dynamics International LLC](https://www.keypedia.com/companies/particle-dynamics-international-llc/db953a3d-b17e-41fa-8606-a4fee44373c1)
- [Pfizer Ireland Pharmaceuticals Unlimited Company](https://www.keypedia.com/companies/pfizer-ireland-pharmaceuticals-unlimited-company/30a59cb5-2d74-4f0d-88bf-dbeca5931111)
- [Gedeon Richter Nyrt.](https://www.keypedia.com/companies/gedeon-richter-nyrt/64f32cb7-f6af-4da0-b8b3-d2f6fee3c19b)